ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,447,197, issued on Oct. 21, was assigned to Elgan Pharma Ltd (Nazareth, Israel).
"Multiparticulate granulate comprising insulin" was invented by Roman Safonov (Ramat-Gan, Israel).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to multiparticulate granulate compositions comprising particles of insulin and particles of an infant nutritional excipient, wherein the multiparticulate granulate is substantially free of layers of insulin and excipient, methods of making thereof, and methods of use thereof."
The patent was filed on Nov. 24, 2022, under Application No. 17/993,916.
*For further information, including images, chart...